1887

Abstract

From March to May 2002, a parvovirus B19 (B19) outbreak was identified at a general hospital that serves as a teaching facility for the Universidad Autónoma de San Luis Potosí, Mexico. Medical students attending the hospital presented with symptoms suggestive of B19 infection. Previous studies have suggested that apparent hospital-related B19 outbreaks may be a reflection of B19 infection in the community. A study was undertaken to assess whether exposure to the hospital was a risk factor for B19 infection and to determine to what extent medical students were infected during this outbreak. The incidence of B19 infection in medical students attending the teaching hospital during the outbreak ( = 211) was determined and compared to students not attending the hospital ( = 96). To assess if a community-wide outbreak had occurred, 80 blood donors were also evaluated for the presence of B19 antibodies. Acute B19 infection was identified in 40 of 119 (33.6 %) susceptible students attending the hospital and in 20 of 47 (42.6 %) susceptible students not attending the hospital. The frequency of acute infection among susceptible blood donors was lower (9.5 %) than in students, but higher than the rate expected during non-epidemic periods. Most infections (68.3 %) were asymptomatic. Symptoms reported by infected subjects were not specific for B19 infection. Only 11.7 % of subjects with acute infection fulfilled the clinical surveillance definition used to detect cases during the outbreak. In conclusion, hospital exposure was not associated to increased risk of B19 infection among medical students. Medical students may be at increased risk for acquiring and transmitting B19 infection during outbreaks.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.05417-0
2004-02-01
2024-03-29
Loading full text...

Full text loading...

/deliver/fulltext/jmm/53/2/JM530211.html?itemId=/content/journal/jmm/10.1099/jmm.0.05417-0&mimeType=html&fmt=ahah

References

  1. Adler S. P., Manganello A. M., Koch W. C., Hempfling S. H., Best A. M. 1993; Risk of human parvovirus B19 infections among school and hospital employees during endemic periods. J Infect Dis 168:361–368 [CrossRef]
    [Google Scholar]
  2. Anand A., Gray E. S., Brown T., Clewley J. P., Cohen B. J. 1987; Human parvovirus infection in pregnancy and hydrops fetalis. N Engl J Med 316:183–186 [CrossRef]
    [Google Scholar]
  3. Anderson M. J., Jones S. E., Fisher-Hoch S. P., Lewis E., Hall S. M., Bartlett C. L., Cohen B. J., Mortimer P. P., Pereira M. S. 1983; Human parvovirus, the cause of erythema infectiosum (fifth disease)?. Lancet i:1378
    [Google Scholar]
  4. Bell L. M., Naides S. J., Stoffman P., Hodinka R. L., Plotkin S. A. 1989; Human parvovirus B19 infection among hospital staff members after contact with infected patients. N Engl J Med 321:485–491 [CrossRef]
    [Google Scholar]
  5. Brown K. E. 2000; Parvovirus B19. In Mandell, Douglas and Bennett's Principles and Practice of Infectious Diseases . , 5th edn. pp 1685–1693 Edited by Mandell G. E., Bennett J. E., Dolin R. Philadelphia: Churchill Livingstone;
  6. Chorba T., Coccia P., Holman R. C. & 10 other authors; 1986; The role of parvovirus B19 in aplastic crisis and erythema infectiosum (fifth disease). J Infect Dis 154:383–393 [CrossRef]
    [Google Scholar]
  7. Dowell S. F., Török T. J., Thorp J. A., Hedrick J., Erdman D. D., Zaki S. R., Hinkle C. J., Bayer W. L., Anderson L. J. 1995; Parvovirus B19 infection in hospital workers: community or hospital acquisition?. J Infect Dis 172:1076–1079 [CrossRef]
    [Google Scholar]
  8. Evans J. P. M., Rossiter M. A., Kumaran T. O., Marsh G. W., Mortimer P. P. 1984; Human parvovirus aplasia: case due to cross infection in a ward. Br Med J (Clin Res Ed) 288:681
    [Google Scholar]
  9. Farr R. W., Hutzel D., D'Aurora R., Rugino T. 1996; Parvovirus B19 outbreak in a rehabilitation hospital. Arch Phys Med Rehabil 77:208–210 [CrossRef]
    [Google Scholar]
  10. Gillespie S. M., Cartter M. L., Asch S., Rokos J. B., Gary G. W., Tsou C. J., Hall D. B., Anderson L. J., Hurwitz E. S. 1990; Occupational risk of human parvovirus B19 infection for school and day-care personnel during an outbreak of erythema infectiosum. JAMA (J Am Med Assoc) 263:2061–2065 [CrossRef]
    [Google Scholar]
  11. Heegaard E. D., Petersen B. L., Heilmann C. J., Hornsleth A. 2002; Prevalence of parvovirus B19 and parvovirus V9 DNA and antibodies in paired bone marrow and serum samples from healthy individuals. J Clin Microbiol 40:933–936 [CrossRef]
    [Google Scholar]
  12. Kelleher J. F. Jr, Luban N. L. C., Cohen B. J., Mortimer P. P. 1984; Human serum parvovirus as the cause of aplastic crisis in sickle cell disease. Am J Dis Child 138:401–403
    [Google Scholar]
  13. Kuo S. H., Lin L. I., Chang C. J., Liu Y. R., Lin K. S., Cheng A. L. 2002; Increased risk for parvovirus B19 infection in young adult cancer patients receiving multiple courses of chemotherapy. J Clin Microbiol 40:3909–3912 [CrossRef]
    [Google Scholar]
  14. Miyamoto K., Ogami M., Takahashi Y., Mori T., Akimoto S., Terashita H., Terashita T. 2000; Outbreak of human parvovirus B19 in hospital workers. J Hosp Infect 45:238–241 [CrossRef]
    [Google Scholar]
  15. Morgan-Capner P., Wright J., Longley J. P., Anderson M. J. 1987; Sex ratio in outbreaks of parvovirus B19 infection. Lancet ii:98
    [Google Scholar]
  16. Nunoue T., Okochi K., Mortimer P. P., Cohen B. J. 1985; Human parvovirus (B19) and erythema infectiosum. J Pediatr 107:38–40 [CrossRef]
    [Google Scholar]
  17. Pillay D., Patou G., Hurt S., Kibbler C. C., Griffiths P. D. 1992; Parvovirus B19 outbreak in a children's ward. Lancet 339:107–109 [CrossRef]
    [Google Scholar]
  18. Plummer F. A., Hammond G. W., Forward K., Sekla L., Thompson L. M., Jones S. E., Kidd I. M., Anderson M. J. 1985; An erythema infectiosum-like illness caused by human parvovirus infection. N Engl J Med 313:74–79 [CrossRef]
    [Google Scholar]
  19. Rao K. R. P., Patel A. R., Anderson M. J., Hodgson J., Jones S. E., Pattison J. R. 1983; Infection with parvovirus-like virus and aplastic crisis in chronic haemolytic anemia. Ann Intern Med 98:930–932 [CrossRef]
    [Google Scholar]
  20. Ray S. M., Erdman D. D., Berschling J. D., Cooper J. E., Török T. J., Blumberg H. M. 1997; Nosocomial exposure to parvovirus B19: low risk of transmission to healthcare workers. Infect Control Hosp Epidemiol 18:109–114 [CrossRef]
    [Google Scholar]
  21. Reid D. M., Reid T. M. S., Brown T., Rennie J. A. N., Eastmond C. J. 1985; Human parvovirus-associated arthritis: a clinical and laboratory description. Lancet i422–425
    [Google Scholar]
  22. Tolfvenstam T., Rudén U., Broliden K. 1996; Evaluation of serological assays for identification of parvovirus B19 immunoglobulin M. Clin Diagn Lab Immunol 3:147–150
    [Google Scholar]
  23. White D. G., Woolf A. D., Mortimer P. P., Cohen B. J., Blake D. R., Bacon P. A. 1985; Human parvovirus arthropathy. Lancet i419–421
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.05417-0
Loading
/content/journal/jmm/10.1099/jmm.0.05417-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error